11月12日下午，中科院成都信息技术股份有限公司（以下简称"公司"）在公司会议室接待了机构及个人 投资者的现场参观调研。本次调研参与机构包括浙商证券、光华上智、昱奕资产、浙商银行、海子基 金、旷谷投资等6家，另有多位个人投资者参与。公司董事会秘书刘小兵、董事会办公室主任兼证券事 务代表吴琳琳就公司核心技术、业务进展、业绩预期及战略规划等核心问题与投资者进行了深入交流。 谈及核心业务定位，公司指出，现有业务覆盖人工智能、机器人、数字经济、机器视觉、信创、医疗等 多个领域，其中最核心的板块为人工智能、机器视觉及信创。 调研中，机构首先关注公司高速机器视觉技术的核心竞争力。公司方面解释，高速机器视觉与传统机器 视觉的关键区别在于，能否在保证检测高精度的前提下，实现检测速度高于设备生产运行速度，并处理 大批量数据。其技术优势集中在大批量连续制造生产场景，可实时完成产品缺陷检测、大规模数据采集 分析及人机交互，实现残次品精准剔除。 新签订单创新高 信创业务贡献3.3亿订单 针对业绩表现，公司表示，去年及今年前三季度业绩暂未达预期，主要受两方面因素影响：一是各行业 客户项目实施周期不同，部分项目尚未完成验收确认营业收入； ...

Group 1: Company Performance - The company achieved a new high in new contract signing, with a growth of 282.6% in 2025 [2][3] - Despite the increase in new contracts, revenue and profit showed a year-on-year decline due to the timing of contract signing and project implementation cycles [3][4] - The company has confidence in revenue recognition by year-end and next year's performance as projects progress [3] Group 2: Business Lines and Core Competencies - The company has diversified into multiple business lines, supported by a history of research and development in various fields [4] - Core competencies are built around high-speed machine vision technology, serving industries such as tobacco, oil and gas, and printing [4] - The current business segments include smart governance, intelligent manufacturing, smart cities, and smart healthcare [4] Group 3: Future Directions and Innovations - The company plans to focus on the development of domestic alternatives in line with national industrial policies [5][6] - In the smart healthcare sector, the company promotes intelligent anesthesia robots, which assist but do not replace doctors [7] - The company is actively developing a digital meeting system and low-code development platforms, enhancing its capabilities in the smart governance sector [6] Group 4: Financial Management and Challenges - The increase in accounts receivable is manageable, primarily due to the nature of large engineering projects and the funding cycles of government and large enterprises [8] - The company maintains a low percentage of receivables over five years, indicating controlled risk [8] Group 5: Market Impact and Adaptation - The digitalization of currency is seen as a complement to physical currency, with no significant impact on the company's printing business [9] - The demand for physical currency is expected to rise due to the internationalization of the RMB and the "Belt and Road" initiative [9] Group 6: Product Development and Technology - The company is developing intelligent agents to enhance its low-code development platform, improving efficiency in data querying and software testing [10] - Approximately 330 million RMB in new orders are attributed to the domestic alternative business, with growth in existing industry sectors contributing to overall performance [10][11]

Core Viewpoint - The company Zhongke Information (300678) is focusing on specific sectors such as smart governance, intelligent manufacturing, smart cities, and smart healthcare, rather than expanding into areas like intelligent driving and humanoid robots [2]. Group 1: Company Performance - As of October 10, 2025, Zhongke Information's stock closed at 35.39 yuan, down 1.39%, with a turnover rate of 2.54% and a trading volume of 74,000 shares, resulting in a transaction amount of 265 million yuan [1]. - On the same day, the net outflow of main funds was 6.8041 million yuan, while the net inflow of speculative funds was 6.972 million yuan, and retail investors experienced a net outflow of 167,900 yuan [2]. Group 2: Business Focus - The company has developed intelligent anesthesia robots for the medical field and intelligent loading and paving robots for the construction sector, showcasing its commitment to specific applications rather than broader fields like intelligent driving [2].

Core Viewpoint - The company focuses on four business sectors: smart government affairs, intelligent manufacturing, smart cities, and smart healthcare, emphasizing technology research and market development [1] Business Segments - The company has independently developed intelligent anesthesia robots for the healthcare sector and intelligent loading and paving robots for the construction sector [1] - The company's high-speed machine vision and intelligent analysis technology have broad applicability across multiple industry fields [1] Current Business Focus - Currently, the company does not have any business related to intelligent driving or humanoid robots [1]

Group 1 - The core theme of the forum was "Future Industries and State Capital Empowering Listed Companies," with over 300 listed companies and 250 state-owned representatives attending [2] - Zhongke Information was awarded the title of "Future Information Industry Star Listed Company" for its innovative practices and contributions to the industry [2] - The company has been a pioneer in using artificial intelligence to assist in the digital transformation of various sectors, including smart governance, intelligent manufacturing, smart cities, and smart healthcare [2][3] Group 2 - Zhongke Information is recognized as a leading enterprise in the artificial intelligence industry chain in Sichuan Tianfu New Area and has been selected as one of the first batch of "Intelligent Transformation and Digital Upgrade" suppliers in Sichuan Province [3] - The company has successfully developed and implemented several innovative products, including the EIOD edge intelligent industrial internet platform and various AI products for specific industries [3] - The company aims to focus on high-quality development, optimize its business layout, and enhance its operational and sustainable development capabilities to contribute to industry prosperity and the capital market's high-quality growth [3]

Core Viewpoint - The company is actively developing intelligent robots for various sectors, including medical and construction, and is exploring the application of machine vision technology in humanoid robots [2]. Group 1: Company Developments - The company has independently developed an intelligent anesthesia robot for the medical field, which has successfully completed its first clinical trial and is undergoing certification as a Class III medical device [2]. - The intelligent loading robot and intelligent paving robot are multi-modal products that integrate machine vision, intelligent analysis, autonomous driving, and radar communication technologies [2]. - The intelligent loading robot (Phase I) has entered the trial phase, while the intelligent paving robot is currently in the testing phase [2]. Group 2: Industry Applications - The company's high-speed machine vision and intelligent analysis technologies have broad applicability across multiple industry sectors [2]. - There is currently no related business in humanoid robots, but the company is open to exploring collaborations with leading domestic and international humanoid robot companies [2].

Group 1: Company Ownership and Control - The actual controller, China Academy of Sciences Holdings Co., Ltd. (CAS Holdings), directly holds 30.53% of the company's shares, maintaining absolute control and leadership [3] - CAS Holdings positions the company as a leader in the artificial intelligence sector, providing resource support [3] Group 2: Strategic Partnerships - The company has had a strategic partnership with West China Hospital for nearly twenty years, focusing on deep collaboration across various departments [4] - The partnership leverages medical big data and artificial intelligence technologies to create specialized solutions and products [4] Group 3: Product Development and Commercialization - The intelligent anesthesia robot has successfully completed its first clinical trial, with plans to obtain Class III medical device certification by the end of 2028 [5] - The company is developing a comprehensive solution for smart hospitals centered around the intelligent anesthesia robot and tumor adaptive radiotherapy platform [5] - The intelligent loading robot is currently in trial use within the Road and Bridge Group, with market promotion underway [6][7] Group 4: Revenue Sources and Business Segments - The main revenue sources include the tobacco business (28%-35% of revenue) and digital conference services (26%-32% of revenue), with other contributions from government, energy, and healthcare sectors [8] - The company has not yet developed brain-computer interface (BCI) technology but is exploring its application in smart medical services [9] Group 5: Technological Advancements and Research - The company has established a doctoral and master's training program at the University of the Chinese Academy of Sciences, supported by an automated reasoning laboratory led by academicians [11] - It has developed a full industrial chain layout for machine vision, ensuring the integration of basic research, key technologies, and industry applications [11]

Core Viewpoint - The company focuses on breakthroughs in intelligent manufacturing and smart city solutions, leveraging high-speed machine vision and big data technologies to provide services across various sectors [2]. Group 1: Business Focus - The company's main business revolves around high-speed machine vision and big data core technologies, providing information technology engineering and related product services for smart governance and intelligent manufacturing [2]. - The company emphasizes the application of its core technologies in more niche areas, particularly in intelligent manufacturing and smart city initiatives [2]. Group 2: Robotics Business - The intelligent loading robot for smart construction integrates machine vision and radar technologies, achieving a precision recognition capability of 5 cm, which is ahead of domestic standards [3]. - The robot can operate collaboratively without human control and can work 24 hours a day in the absence of lighting, with successful trials conducted with road and bridge groups [3]. - The intelligent anesthesia assistance robot has completed its first clinical trial, providing new solutions for surgical anesthesia applicable in various hospitals [3]. Group 3: Growth in Trustworthy Innovation Field - The company has made significant strides in the trustworthy innovation sector, particularly in smart governance, with the digital conference system achieving localization [4]. - Multiple projects have been delivered to provincial and municipal levels, enhancing government information technology [4]. - The company is actively working on platform localization modifications and has completed adaptation certifications [4]. Group 4: Capital Operations and R&D Investment - The company prioritizes capital operations and plans to utilize various financing methods to promote the industrialization of research outcomes [5]. - The annual R&D investment is approximately 40 million yuan, accounting for 6% to 8% of operating revenue, with a 15.74% year-on-year increase in R&D expenses this year [5]. - The company is developing brain-computer interface technologies for applications in intelligent anesthesia and smart rehabilitation, with its core machine vision technology being internationally advanced and domestically leading [5].

Business Overview - The company focuses on high-speed machine vision and big data technologies, providing AI-based information engineering and services across various sectors including smart governance, intelligent manufacturing, smart cities, and smart healthcare [3] - The main emphasis is on intelligent manufacturing and smart city initiatives, aiming to enhance productivity and digital transformation [3] Robotics Development - The company has developed intelligent loading robots for the smart construction sector, featuring multi-modal technologies with a precision detection capability of 5CM, exceeding domestic standards [4] - The robots can operate autonomously in various conditions, significantly reducing costs and enhancing efficiency [4] - A second-generation product is in design, and a collaborative intelligent paving robot is in testing [4] Smart Anesthesia Robot - The intelligent anesthesia robot has successfully completed its first clinical trial, demonstrating its ability to provide precise decision-making and real-time drug administration [5][8] - This innovation addresses the domestic gap in smart anesthesia technology and enhances surgical safety [5] Digital Governance and Orders - The company has seen significant growth in orders, particularly in the digital governance sector, with a focus on domestic product localization [6] - Key products include a digital meeting system and various information technology projects implemented across multiple provinces [6] R&D Investment - The company invests approximately 40 million CNY annually in R&D, accounting for 6% to 8% of its revenue, with a year-on-year increase in R&D spending by 15.74% [10] - The R&D team is extensive, with many personnel involved in product development across various sectors [10] Machine Vision Technology - The company's core technology in high-speed machine vision is at an internationally advanced level, utilizing AI and machine learning for enhanced detection accuracy and speed [9][10] - A complete industrial chain for machine vision has been established, ensuring stable and reliable domestic AI products for quality detection in traditional manufacturing [10]

Group 1: Business Performance - The company reported a significant increase in new contract amounts, driven by growth in various business sectors, particularly in artificial intelligence and digital transformation solutions [3] - Revenue from the tobacco sector grew by 35.56% year-on-year due to increased demand for digital solutions [3] - The oil and gas information sector saw a remarkable revenue increase of 95.85%, particularly in digital oilfield services [3] Group 2: Innovation and Technology - The company is a founding member of the Sichuan and Chengdu Innovation Alliance, actively participating in local innovation initiatives and establishing a resource library for domestic products [3] - The company has completed the localization of several self-developed products, including election systems and integrated control platforms for the oil industry [3] - The establishment of the "Brain Cognition and Smart Medical Innovation Application Laboratory" aims to develop advanced medical technologies, including smart anesthesia robots and IoT medical devices [5][6] Group 3: Strategic Partnerships and Future Plans - The company has a long-standing partnership with Sichuan University West China Hospital, focusing on the development of AI-driven medical solutions [6] - A framework agreement was signed with Suzhou Nano Institute to collaborate on brain science and smart medical applications, targeting high-end intelligent medical devices [6] - The company is committed to expanding its ecosystem through capital operations and partnerships with research institutions [6] Group 4: Market Position and Management Confidence - The company is positioned as a key player in the artificial intelligence sector, with a strong market outlook and confidence in future growth [6] - Recent stock sales by executives are attributed to personal needs and do not reflect a lack of confidence in the company's future [6]